KLP
BBNX

Kent Lake PR’s Beta Bionics BBNX Stock Holding History

Kent Lake PR’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$2.48M Buy
+125,000
New +$2.2M 1.25% 29

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Kent Lake PR's BBNX Position: Q3 2025 in Review

Kent Lake PR opened a new position in Beta Bionics (BBNX) in Q3 2025: 125,000 shares worth $2.48M. The stake represents 1.25% of the portfolio and ranks #29 among its holdings.

129 funds tracked by Wall St. Rank hold BBNX as of Q3 2025.

  • Kent Lake PR held 125,000 shares of Beta Bionics worth $2.48M as of Q3 2025.
  • Beta Bionics was a new Kent Lake PR position in Q3 2025.
  • Beta Bionics made up 1.25% of Kent Lake PR's portfolio in Q3 2025, its #29 holding.
  • 129 funds tracked by Wall St. Rank held Beta Bionics as of Q3 2025.

Based on Kent Lake PR's 13F filing for Q3 2025, filed 14 Nov 2025.